The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The closing price of Quantum BioPharma Ltd (NASDAQ: QNTM) was $12.15 for the day, down -0.82% from the previous closing price of $12.25. In other words, the price has decreased by -$0.82 from its previous closing price. On the day, 0.65 million shares were traded. QNTM stock price reached its highest trading level at $13.6 during the session, while it also had its lowest trading level at $11.45.
Ratios:
Our analysis of QNTM’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.76 and its Current Ratio is at 3.76. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, QNTM now has a Market Capitalization of 23320710 and an Enterprise Value of 3974936.
Stock Price History:
The Beta on a monthly basis for QNTM is 0.29, which has changed by -0.7769686 over the last 52 weeks, in comparison to a change of 0.21313763 over the same period for the S&P500. Over the past 52 weeks, QNTM has reached a high of $70.85, while it has fallen to a 52-week low of $2.70. The 50-Day Moving Average of the stock is 165.19%, while the 200-Day Moving Average is calculated to be 41.93%.
Shares Statistics:
QNTM traded an average of 2.34M shares per day over the past three months and 13645530 shares per day over the past ten days. A total of 1.86M shares are outstanding, with a floating share count of 1.59M. Insiders hold about 17.20% of the company’s shares, while institutions hold 2.51% stake in the company. Shares short for QNTM as of 1738281600 were 54391 with a Short Ratio of 0.02, compared to 1735603200 on 59477. Therefore, it implies a Short% of Shares Outstanding of 54391 and a Short% of Float of 2.97.
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
